Integral Derivatives’s Chemours CC Stock Holding History

Integral Derivatives’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-14,888	Closed	-$74.8K	–	879
2015 Q4	$80K	Buy	14,888 +4,800	+48%	+$30.7K	﹤0.01%	1002
2015 Q3	$65K	Buy	+10,088	New	+$106K	﹤0.01%	1025

Other funds holding CC

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Integral Derivatives's CC Position: Q1 2016 in Review

Integral Derivatives sold out of Chemours (CC) in Q1 2016, closing a stake of 14,888 shares — an estimated $74.8K sold.

Integral Derivatives first reported a position in CC in Q3 2015 and held it in 2 quarters. The position peaked at $80K in Q4 2015. 416 funds tracked by Wall St. Rank hold CC as of Q1 2016.

Integral Derivatives reported no remaining Chemours position as of Q1 2016 after selling out during the quarter.
Integral Derivatives sold 14,888 Chemours shares in Q1 2016, an estimated $74.8K.
Integral Derivatives first reported a position in Chemours in Q3 2015 and held it in 2 quarters.
Integral Derivatives's Chemours position peaked at $80K in Q4 2015.
416 funds tracked by Wall St. Rank held Chemours as of Q1 2016.

Based on Integral Derivatives's 13F filing for Q1 2016, filed 12 Apr 2016.